BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31286302)

  • 1. Salivary metabolomics with alternative decision tree-based machine learning methods for breast cancer discrimination.
    Murata T; Yanagisawa T; Kurihara T; Kaneko M; Ota S; Enomoto A; Tomita M; Sugimoto M; Sunamura M; Hayashida T; Kitagawa Y; Jinno H
    Breast Cancer Res Treat; 2019 Oct; 177(3):591-601. PubMed ID: 31286302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary metabolomics with machine learning for colorectal cancer detection.
    Kuwabara H; Katsumata K; Iwabuchi A; Udo R; Tago T; Kasahara K; Mazaki J; Enomoto M; Ishizaki T; Soya R; Kaneko M; Ota S; Enomoto A; Soga T; Tomita M; Sunamura M; Tsuchida A; Sugimoto M; Nagakawa Y
    Cancer Sci; 2022 Sep; 113(9):3234-3243. PubMed ID: 35754317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic approach to breast cancer patients based on target metabolomics in saliva by liquid chromatography with tandem mass spectrometry.
    Takayama T; Tsutsui H; Shimizu I; Toyama T; Yoshimoto N; Endo Y; Inoue K; Todoroki K; Min JZ; Mizuno H; Toyo'oka T
    Clin Chim Acta; 2016 Jan; 452():18-26. PubMed ID: 26523874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
    Zhong L; Cheng F; Lu X; Duan Y; Wang X
    Talanta; 2016 Sep; 158():351-360. PubMed ID: 27343615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary metabolomic biomarkers for non-invasive lung cancer detection.
    Kajiwara N; Kakihana M; Maeda J; Kaneko M; Ota S; Enomoto A; Ikeda N; Sugimoto M
    Cancer Sci; 2024 May; 115(5):1695-1705. PubMed ID: 38417449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics.
    Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M
    Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of salivary metabolomic biomarkers for oral cancer screening.
    Ishikawa S; Sugimoto M; Kitabatake K; Sugano A; Nakamura M; Kaneko M; Ota S; Hiwatari K; Enomoto A; Soga T; Tomita M; Iino M
    Sci Rep; 2016 Aug; 6():31520. PubMed ID: 27539254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of timing of collection of salivary metabolomic biomarkers on oral cancer detection.
    Ishikawa S; Sugimoto M; Kitabatake K; Tu M; Sugano A; Yamamori I; Iba A; Yusa K; Kaneko M; Ota S; Hiwatari K; Enomoto A; Masaru T; Iino M
    Amino Acids; 2017 Apr; 49(4):761-770. PubMed ID: 28101653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Polyamine Biomarker Panels with Machine-Learning Differentiated Colorectal Cancers, Benign Disease, and Healthy Controls.
    Nakajima T; Katsumata K; Kuwabara H; Soya R; Enomoto M; Ishizaki T; Tsuchida A; Mori M; Hiwatari K; Soga T; Tomita M; Sugimoto M
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary metabolites are promising noninvasive biomarkers of drug-induced liver injury.
    Yu SM; Zheng HC; Wang SC; Rong WY; Li P; Jing J; He TT; Li JH; Ding X; Wang RL
    World J Gastroenterol; 2024 May; 30(18):2454-2466. PubMed ID: 38764769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary metabolomics for oral leukoplakia with and without dysplasia.
    Kitabatake K; Ishikawa S; Sugimoto M; Enomoto A; Kaneko M; Ota S; Edamatsu K; Yusa K; Hemmi T; Okuyama N; Iino M
    J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101618. PubMed ID: 37659754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
    Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
    Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning models in breast cancer survival prediction.
    Montazeri M; Montazeri M; Montazeri M; Beigzadeh A
    Technol Health Care; 2016; 24(1):31-42. PubMed ID: 26409558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of storage conditions on salivary polyamines quantified via liquid chromatography-mass spectrometry.
    Tomita A; Mori M; Hiwatari K; Yamaguchi E; Itoi T; Sunamura M; Soga T; Tomita M; Sugimoto M
    Sci Rep; 2018 Aug; 8(1):12075. PubMed ID: 30104641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast.
    Streckfus CF; Mayorga-Wark O; Arreola D; Edwards C; Bigler L; Dubinsky WP
    Cancer Invest; 2008 Mar; 26(2):159-67. PubMed ID: 18259946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTIR-based spectrum of salivary exosomes coupled with computational-aided discriminating analysis in the diagnosis of oral cancer.
    Zlotogorski-Hurvitz A; Dekel BZ; Malonek D; Yahalom R; Vered M
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):685-694. PubMed ID: 30603907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: a machine learning approach.
    Lin FP; Pokorny A; Teng C; Dear R; Epstein RJ
    BMC Cancer; 2016 Dec; 16(1):929. PubMed ID: 27905893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.
    Itoi T; Sugimoto M; Umeda J; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Moriyasu F; Kasuya K; Nagakawa Y; Abe Y; Takano K; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using post-column infused internal standard assisted quantitative metabolomics for establishing prediction models for breast cancer detection.
    Huang M; Li HY; Liao HW; Lin CH; Wang CY; Kuo WH; Kuo CH
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8581. PubMed ID: 31693758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of molecular subtypes of breast cancer using BI-RADS features based on a "white box" machine learning approach in a multi-modal imaging setting.
    Wu M; Zhong X; Peng Q; Xu M; Huang S; Yuan J; Ma J; Tan T
    Eur J Radiol; 2019 May; 114():175-184. PubMed ID: 31005170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.